Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herling

Showing results (41-50 of 569) with videos related to

Pageof 57
Sort By:
Oncotarget|February 1, 2018
Nucleotide excision repair as a targetable vulnerability in leukemiaGregor Lohmann, Björn Schumacher, Marco Herling
Oncotarget|May 4, 2023
AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and functionTill Braun, Hanna Klepzig, Marco Herling
Pediatric Cardiology|October 18, 2025
Drug-Eluting Balloons Versus Conventional Balloon Angioplasty for Peripheral Pulmonary Artery Stenosis in ChildhoodTimo J Herling, Peter A Zartner
Signal Transduction and Targeted Therapy|September 3, 2024
"Clone-specific" antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancersDennis Jungherz, Philipp Lückemeier, Marco Herling
Das Deutsche Gesundheitswesen|May 21, 1970
[Current problems of pharmacotherapy. 8. Stationary and ambulatory treatment with drugs. 1]P Oehme, G Brüschke, M Herling
Radiation Research|February 1, 1977
Energy transfer to hydrogen by neutrons from 30 to 100 MeVR H Bassel, G H Herling
Journal of the American Chemical Society|April 19, 2023
Ratiometric, pH-Sensitive Probe for Monitoring siRNA DeliveryMadison R Herling, Ivan J Dmochowski
Food and Drug Law Journal|November 25, 2005
Global medicine does not make for global courtsDaniel J Herling, Lina M Brenner
Human Mutation|June 10, 2017
Semi-automated cancer genome analysis using high-performance computingGiuliano Crispatzu, Pranav Kulkarni, Mohammad R Toliat, et al.
Physical Review. B, Condensed Matter|December 1, 1993
Comment on "Nuclear resonant absorption in long-lived isomeric transitions"Balko, Kay, Nicoll, et al.
Pageof 57

Showing results (41-50 of 569) with videos related to

Sort By:
Pageof 57
Oncotarget|February 1, 2018
Nucleotide excision repair as a targetable vulnerability in leukemiaGregor Lohmann, Björn Schumacher, Marco Herling
Oncotarget|May 4, 2023
AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and functionTill Braun, Hanna Klepzig, Marco Herling
Pediatric Cardiology|October 18, 2025
Drug-Eluting Balloons Versus Conventional Balloon Angioplasty for Peripheral Pulmonary Artery Stenosis in ChildhoodTimo J Herling, Peter A Zartner
Signal Transduction and Targeted Therapy|September 3, 2024
"Clone-specific" antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancersDennis Jungherz, Philipp Lückemeier, Marco Herling
Das Deutsche Gesundheitswesen|May 21, 1970
[Current problems of pharmacotherapy. 8. Stationary and ambulatory treatment with drugs. 1]P Oehme, G Brüschke, M Herling
Radiation Research|February 1, 1977
Energy transfer to hydrogen by neutrons from 30 to 100 MeVR H Bassel, G H Herling
Journal of the American Chemical Society|April 19, 2023
Ratiometric, pH-Sensitive Probe for Monitoring siRNA DeliveryMadison R Herling, Ivan J Dmochowski
Food and Drug Law Journal|November 25, 2005
Global medicine does not make for global courtsDaniel J Herling, Lina M Brenner
Human Mutation|June 10, 2017
Semi-automated cancer genome analysis using high-performance computingGiuliano Crispatzu, Pranav Kulkarni, Mohammad R Toliat, et al.
Physical Review. B, Condensed Matter|December 1, 1993
Comment on "Nuclear resonant absorption in long-lived isomeric transitions"Balko, Kay, Nicoll, et al.
Pageof 57